International Stem Cell Corporation
ISCO
$0.11
-$0.001-0.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.09M | 8.53M | 8.32M | 7.83M | 7.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.09M | 8.53M | 8.32M | 7.83M | 7.79M |
| Cost of Revenue | 3.76M | 3.64M | 3.44M | 3.24M | 3.18M |
| Gross Profit | 5.32M | 4.89M | 4.88M | 4.59M | 4.61M |
| SG&A Expenses | 5.24M | 5.33M | 5.36M | 5.40M | 5.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.15M | 9.07M | 8.87M | 8.68M | 8.45M |
| Operating Income | -68.00K | -543.00K | -550.00K | -843.00K | -663.00K |
| Income Before Tax | -209.00K | -678.00K | -684.00K | -311.00K | -131.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.21 | -0.68 | -0.68 | -0.31 | -0.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -209.00K | -678.00K | -684.00K | -311.00K | -131.00K |
| EBIT | -68.00K | -543.00K | -550.00K | -843.00K | -663.00K |
| EBITDA | 138.00K | -343.00K | -356.00K | -651.00K | -469.00K |
| EPS Basic | -0.03 | -0.07 | -0.07 | -0.05 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.05 | -0.05 | -0.08 | -0.06 |
| EPS Diluted | -0.04 | -0.08 | -0.08 | -0.05 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.05 | -0.05 | -0.08 | -0.06 |
| Average Basic Shares Outstanding | 32.02M | 32.02M | 32.02M | 32.02M | 32.02M |
| Average Diluted Shares Outstanding | 32.02M | 32.02M | 32.02M | 32.02M | 32.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |